)
Clarivate (CLVT) investor relations material
Clarivate Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Life Sciences & Healthcare sale closed October 6, shifting the portfolio focus to Academia & Government and Intellectual Property; ongoing revenue mix is 93% recurring.
Q3 organic ACV growth was 1.8%, up 30 bps YoY, and recurring organic revenue growth was 1.3%, up 110 bps YoY; management cited improving momentum.
Priorities include accelerating sustained organic growth, expanding free cash flow and reducing leverage.
Financial highlights
Q3 continuing-operations revenue was $481.6M, down 9.2% YoY, mainly from inorganic disposals; total revenue including discontinued operations was $567.9M.
Continuing-operations Adjusted EBITDA was $218.2M, with a 45.3% margin versus 41.9% a year earlier; total-company Adjusted EBITDA including discontinued operations was $245.3M.
Q3 continuing-operations net loss was $26.4M versus $24.9M; adjusted diluted EPS was $0.21 versus $0.18.
Q3 operating cash flow was $166M and free cash flow was $110M; 9M operating cash flow was $399.0M and free cash flow was $233.1M.
9M continuing-operations revenue was $1,472.4M, down 4.8%; continuing-operations net loss narrowed to $122.3M from $213.3M.
Outlook and guidance
FY26 guidance: revenue $1.965B-$1.985B; Adjusted EBITDA $865M-$885M, or 43%-45% margin; adjusted diluted EPS $0.73-$0.77.
FY26 organic ACV growth is guided at 1.75%-2.25%, recurring organic revenue growth at 1%-1.5%, and free cash flow at $320M-$340M.
Q4 outlook: revenue $865M-$885M, Adjusted EBITDA $215M-$235M, 44%-46% margin, adjusted diluted EPS $0.14-$0.18, and free cash flow $85M-$105M.
FY27 perspective: free cash flow of $350M-$400M and net leverage of 3.5x-3.6x, versus ~4x in FY26; full 2027 guidance planned for February.
FY26 free cash flow reflects working-capital and sale-closing timing; FY26 guidance includes LS&H results for the first nine months and excludes them for Q4.
- Q2 2026 revenues fell 5.5% to $587.3M; strong margins and LS&H divestiture to reduce debt.CLVT
Q2 2026 - $600M LS&H divestiture sharpens focus, boosts margins, and strengthens financial outlook.CLVT
M&A announcement - Q1 2026 saw margin expansion, debt reduction, and progress on LS&H segment divestiture.CLVT
Q1 2026 - Votes will be held on director re-elections, executive pay, and auditor reappointment.CLVT
Proxy filing - Annual meeting to vote on directors, executive pay, and auditor, with strong governance focus.CLVT
Proxy filing - Accelerating recurring revenue and AI-driven innovation while divesting Life Sciences to boost growth.CLVT
Wolfe FinTech Forum - Exceeded guidance, improved recurring revenue, and set 2026 growth targets amid portfolio shift.CLVT
Q4 2025 - Q2 revenue fell and net loss widened on impairment, but guidance and renewal rates held firm.CLVT
Q2 2024 - Guidance lowered for organic growth, but AI innovation and buybacks signal a strategic shift.CLVT
Oppenheimer 27th Virtual Annual Technology, Internet & Communications Conference
Next Clarivate earnings date
Next Clarivate earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)